Drugplain

Ergocalciferol 1.25 mg/1

Ergocalciferol · CAPSULE, LIQUID FILLED · St. Mary's Medical Park Pharmacy

2 Recalls on Record
Plain English

Ergocalciferol is a form of vitamin D (vitamin D2) used to treat or prevent vitamin D deficiency and related conditions affecting bone health and calcium absorption. It comes as an oral capsule and is available by prescription.

Key Facts

Brand Name
Ergocalciferol
Generic Name
Ergocalciferol
NDC Code (Product)
60760-152
Manufacturer
St. Mary's Medical Park Pharmacy
Strength
1.25 mg/1
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Marketing Status
Application #
ANDA080704
Drug Class
Provitamin D2 Compound [EPC]
Marketing Start
06/15/2016

Recall History

2 Recalls on Record
Class II02/17/2025

Safecor Health, LLC

Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

OngoingVoluntary: Firm initiated
Class II11/01/2013

Natures Pharmacy & Compounding Center

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective4,520 reports
fatigue4,268 reports
pain4,193 reports
off label use4,076 reports
dyspnoea3,950 reports
headache3,676 reports
nausea3,662 reports
diarrhoea3,448 reports
vomiting3,322 reports
arthralgia3,296 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS AND USAGE Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.

Dosage & Administration

DOSAGE AND ADMINISTRATION THE RANGE BETWEEN THERAPEUTIC AND TOXIC DOSES IS NARROW. Vitamin D Resistant Rickets: 12,000 to 500,000 USP units daily. Hypoparathyroidism: 50,000 to 200,000 USP units daily concomitantly with calcium lactate 4 g, six times per day. DOSAGE MUST BE INDIVIDUALIZED UNDER CLOSE MEDICAL SUPERVISION. Calcium intake should be adequate. Blood calcium and phosphorous determinations must be made every 2 weeks or more frequently if necessary. X-rays of the bones should be taken every month until condition is corrected and stabilized.

Warnings

WARNINGS Hypersensitivity to vitamin D may be one etiologic factor in infants with idiopathic hypercalcemia. In these cases vitamin D must be strictly restricted. Keep out of the reach of children.

Contraindications

CONTRAINDICATIONS Ergocalciferol is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.

Drug Interactions

Drug Interactions Mineral oil interferes with the absorption of fat-soluble vitamins, including vitamin D preparations. Administration of thiazide diuretics to hypoparathyroid patients who are concurrently being treated with ergocalciferol may cause hypercalcemia.

Adverse Reactions

ADVERSE REACTIONS Hypervitaminosis D is characterized by effects on the following organ system: Renal: Impairment of renal function with polyuria, nocturia, polydipsia, hypercalciuria, reversible azotemia, hypertension, nephrocalcinosis, generalized vascular calcification, or irreversible renal insufficiency which may result in death. CNS: Mental retardation. Soft Tissues: Widespread calcification of the soft tissues, including the heart, blood vessels, renal tubules, and lungs. Skeletal: Bone demineralization (osteoporosis) in adults occurs concomitantly. Decline in the average rate of linear growth and increased mineralization of bones in infants and children (dwarfism), vague aches, stiffness, and weakness. Gastrointestinal: Nausea, anorexia, constipation. Metabolic: Mild acidosis, anemia, weight loss. To report SUSPECTED ADVERSE REACTIONS, contact Bionpharma Inc. at 1-888-235-2466 or FDA at 1-800-FDA-1088 or www.fda.gov/ medwatch.

Frequently Asked Questions

What is Ergocalciferol used for?

Ergocalciferol is a form of vitamin D (vitamin D2) used to treat or prevent vitamin D deficiency and related conditions affecting bone health and calcium absorption. It comes as an oral capsule and is available by prescription.

Is Ergocalciferol a controlled substance?

Ergocalciferol is not classified as a controlled substance by the DEA.

What is the generic name for Ergocalciferol?

The generic name for Ergocalciferol is Ergocalciferol. There are 7 other brand versions of Ergocalciferol.

What is the NDC code for Ergocalciferol 1.25 mg/1?

The NDC (National Drug Code) for Ergocalciferol 1.25 mg/1 is 60760-152, listed by St. Mary's Medical Park Pharmacy.